Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594 · see citing works

The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data

McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · see citing works

ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data

Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,380 · see citing works

An integrated map of genetic variation from 1,092 human genomes

The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711 · see citing works

dbSNP: the NCBI database of genetic variation

Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502 · see citing works

Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples

Cibulskis, K., Lawrence, M. S., Carter, S. L., Sivachenko, A., Jaffe, D. B., Sougnez, C. L., Gabriel, S., Meyerson, M. M., Lander, E. S., & Getz, G. A. (2013) · Nature Biotechnology · doi:10.1038/nbt.2514 · Cited by 4,838 · see citing works

ClinVar: public archive of relationships among sequence variation and human phenotype

Landrum, M. J., Lee, J. M., Riley, G. R., Jang, W., Rubinstein, W. S., Church, D. M., & Maglott, D. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1113 · Cited by 3,516 · see citing works

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., et al. (2013) · Genetics in Medicine · doi:10.1038/gim.2013.73 · Cited by 2,544 · see citing works

DELLY: structural variant discovery by integrated paired-end and split-read analysis

Rausch, T., Zichner, T., Schlattl, A., Stütz, A. M., Beneš, V., & Korbel, J. O. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts378 · Cited by 2,384 · see citing works

Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT)

Cheng, D. T., Mitchell, T. N., Zehir, A., Shah, R. H., Benayed, R., Syed, A., Chandramohan, R., Liu, Z. Y., Won, H. H., Scott, S. N., et al. (2015) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.12.006 · Cited by 2,119 · see citing works

Evolution and functional impact of rare coding variation from deep sequencing of human exomes

Tennessen, J. A., Bigham, A. W., O’Connor, T. D., Fu, W., Kenny, E. E., Gravel, S., McGee, S., Do, R., Liu, X., Jun, G., et al. (2012) · Science · doi:10.1126/science.1219240 · Cited by 1,613 · see citing works

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

Walsh, T., Casadei, S., Lee, M. K., Pennil, C. C., Nord, A. S., Thornton, A., Roeb, W., Agnew, K. J., Stray, S. M., Wickramanayake, A., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115052108 · Cited by 929 · see citing works

Realizing the promise of cancer predisposition genes

Rahman, N. (2014) · Nature · doi:10.1038/nature12981 · Cited by 616 · see citing works

Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing

Walsh, T., Lee, M. K., Casadei, S., Thornton, A., Stray, S. M., Pennil, C. C., Nord, A. S., Mandell, J. B., Swisher, E. M., & King, M. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007983107 · Cited by 485 · see citing works

Personalized genomic analyses for cancer mutation discovery and interpretation

Jones, S., Anagnostou, V., Lytle, K., Parpart-Li, S. T., Nesselbush, M. C., Riley, D. R. J., Shukla, M., Chesnick, B., Kadan, M., Papp, E., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7161 · Cited by 413 · see citing works

Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA

Schrader, K. A., Cheng, D. T., Vijai, J., Prasad, M., Walsh, M. F., Zehir, A., Ni, A., Thomas, T., Benayed, R., Ashraf, A. M., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5208 · Cited by 342 · see citing works

ColoSeq Provides Comprehensive Lynch and Polyposis Syndrome Mutational Analysis Using Massively Parallel Sequencing

Pritchard, C. C., Smith, C., Salipante, S. J., Lee, M. K., Thornton, A., Nord, A. S., Gulden, C., Kupfer, S. S., Swisher, E. M., Bennett, R. L., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.03.002 · Cited by 204 · see citing works

Cancer Genomics and Inherited Risk

Stadler, Z. K., Schrader, K. A., Vijai, J., Robson, M. E., & Offit, K. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.7271 · Cited by 147 · see citing works

Mainstreaming genetic testing of cancer predisposition genes

Rahman, N. (2014) · Clinical Medicine · doi:10.7861/clinmedicine.14-4-436 · Cited by 84 · see citing works

Next-Generation Sequencing of the BRCA1 and BRCA2 Genes for the Genetic Diagnostics of Hereditary Breast and/or Ovarian Cancer

Trujillano, D., Weiss, M. E. R., Schneider, J., Köster, J., Papachristos, E. B., Saviouk, V., Zakharkina, T., Nahavandi, N., Kovačević, L., & Rolfs, A. (2014) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2014.11.004 · Cited by 63 · see citing works

Long-Range PCR and Next-Generation Sequencing of BRCA1 and BRCA2 in Breast Cancer

Özçelik, H., Shi, X., Chang, M. C., Tram, E., Vlasschaert, M., Nicola, N. D., Kiselova, A., Yee, D., Goldman, A. J., Dowar, M., et al. (2012) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2012.03.006 · Cited by 56 · see citing works

Pathogenic Germline Variants in 10,389 Adult Cancers

Huang, K., Mashl, R. J., Wu, Y., Ritter, D., Wang, J., Oh, C., Paczkowska, M., Reynolds, S. M., Wyczalkowski, M. A., Oak, N., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.039 · Cited by 838 · see citing works

Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer

Latham, A. J., Srinivasan, P., Kemel, Y. M., Shia, J., Bandlamudi, C., Mandelker, D. L., Middha, S., Hechtman, J. F., Zehir, A., Dubard-Gault, M. E., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.18.00283 · Cited by 618 · see citing works

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

Mandelker, D. L., Zhang, L., Kemel, Y. M., Stadler, Z. K., Vijai, J., Zehir, A., Pradhan, N., Arnold, A. G., Walsh, M. F., Li, Y., et al. (2017) · JAMA · doi:10.1001/jama.2017.11137 · Cited by 513 · see citing works

Microsatellite instability: a review of what the oncologist should know

Li, K., Luo, H., Huang, L., Luo, H., & Zhu, X. (2020) · Cancer Cell International · doi:10.1186/s12935-019-1091-8 · Cited by 509 · see citing works

Tumour lineage shapes BRCA-mediated phenotypes

Jonsson, P., Bandlamudi, C., Cheng, M. L., Srinivasan, P., Chavan, S. S., Friedman, N. D., Rosen, E. Y., Richards, A. L., Bouvier, N., Selçuklu, S. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1382-1 · Cited by 404 · see citing works

Identification of cancer driver genes based on nucleotide context

Dietlein, F., Weghorn, D., Taylor-Weiner, A. N., Richters, A., Reardon, B. M., Liu, D., Lander, E. S., Allen, E. M. V., & Sunyaev, S. R. (2020) · Nature Genetics · doi:10.1038/s41588-019-0572-y · Cited by 241 · see citing works

Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group

Mandelker, D. L., Donoghue, M. T. A., Talukdar, S., Bandlamudi, C., Srinivasan, P., Vivek, M., Jezdic, S., Hanson, H., Snape, K. M. G., Kulkarni, A., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz136 · Cited by 242 · see citing works

Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma

Ho, A. S., Ochoa, A., Jayakumaran, G., Zehir, A., Valero, C., Tepe, J., Makarov, V., Dalin, M. G., He, J., Bailey, M., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci128227 · Cited by 212 · see citing works

Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma

Carlo, M. I., Mukherjee, S., Mandelker, D. L., Vijai, J., Kemel, Y. M., Zhang, L., Knežević, A., Patil, S., Ceyhan‐Birsoy, O., Huang, K.-C., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.1986 · Cited by 189 · see citing works

Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors

Fiala, E. M., Jayakumaran, G., Mauguen, A., Kennedy, J. A., Bouvier, N., Kemel, Y. M., Fleischut, M. H., Maio, A., Salo‐Mullen, E. E., Sheehan, M. R., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00172-1 · Cited by 172 · see citing works

Alterations in PTEN and ESR1 promote clinical resistance to alpelisib plus aromatase inhibitors

Razavi, P., Dickler, M. N., Shah, P. D., Toy, W., Brown, D. N., Won, H. H., Li, B. T., Shen, R., Vasan, N., Modi, S., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0047-1 · Cited by 160 · see citing works

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q

Jhaveri, K. L., Wang, X. V., Makker, V., Luoh, S.-W., Mitchell, E. P., Zwiebel, J. A., Sharon, E., Gray, R. J., Li, S., McShane, L. M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz291 · Cited by 151 · see citing works

Germline-focused analysis of tumour-detected variants in 49,264 cancer patients: ESMO Precision Medicine Working Group recommendations

Kuzbari, Z., Bandlamudi, C., Loveday, C., Garrett, A., Mehine, M. M., George, A. J., Hanson, H., Snape, K. M. G., Kulkarni, A., Allen, S., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.12.003 · Cited by 150 · see citing works

Clinical Utility of Prospective Molecular Characterization in Advanced Endometrial Cancer

Soumerai, T. E., Donoghue, M. T. A., Bandlamudi, C., Srinivasan, P., Chang, M. T., Zamarin, D., Cadoo, K. A., Grisham, R. N., O'Cearbhaill, R. E., Tew, W. P., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0412 · Cited by 145 · see citing works

A clinical benchmark of public self-supervised pathology foundation models

Campanella, G., Chen, S., Singh, M., Verma, R., Muehlstedt, S., Zeng, J., Stock, A., Croken, M., Veremis, B., Elmas, A., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58796-1 · Cited by 126 · see citing works

Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing

Hensley, M. L., Chavan, S. S., Solit, D. B., Murali, R., Soslow, R. A., Chiang, S., Jungbluth, A. A., Bandlamudi, C., Srinivasan, P., Tap, W. D., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-3959 · Cited by 119 · see citing works

Integrated approaches for precision oncology in colorectal cancer: The more you know, the better

Andrei, P., Battuello, P., Grasso, G., Rovera, E., Tesio, N., & Bardelli, A. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.04.007 · Cited by 113 · see citing works

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival

Varghese, A. M., Perry, M., Chou, J. F., Nandakumar, S., Muldoon, D. M., Erakky, A., Zucker, A., Fong, C. J., Mehine, M. M., Nguyen, B., et al. (2025) · Nature Medicine · doi:10.1038/s41591-024-03362-3 · Cited by 119 · see citing works

The context-specific role of germline pathogenicity in tumorigenesis

Srinivasan, P., Bandlamudi, C., Jonsson, P., Kemel, Y. M., Chavan, S. S., Richards, A. L., Penson, A. V., Bielski, C. M., Fong, C. J., Syed, A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00949-1 · Cited by 107 · see citing works

Molecular profiling and molecular classification of endometrioid ovarian carcinomas

Cybulska, P., Paula, A. D. C., Tseng, J. H., Leitão, M. M., Bashashati, A., Huntsman, D. D., Nazeran, T. M., Aghajanian, C. A., Abu‐Rustum, N. R., DeLair, D. F., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.07.012 · Cited by 101 · see citing works

MAPK Pathway Genetic Alterations Are Associated with Prolonged Overall Survival in Low-Grade Serous Ovarian Carcinoma

Manning-Geist, B., Gordhandas, S., Liu, Y. L., Zhou, Q. C., Iasonos, A. E., Paula, A. D. C., Mandelker, D. L., Roche, K. L., Zivanovic, O., Maio, A., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-4183 · Cited by 93 · see citing works

Clinical Validation of Whole Genome Sequencing for Cancer Diagnostics

Roepman, P., de Bruijn, E., van Lieshout, S., Schoenmaker, L., Boelens, M. C., Dubbink, H. J., Geurts-Giele, W. R. R., Groenendijk, F. H., Huibers, M. M. H., Kranendonk, M. E. G., et al. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.04.011 · Cited by 92 · see citing works

Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability

Raj, N. P., Shah, R. H., Stadler, Z. K., Mukherjee, S., Chou, J. F., Untch, B. R., Li, J., Kelly, V., Osoba, M., Saltz, L. B., et al. (2018) · JCO Precision Oncology · doi:10.1200/po.17.00267 · Cited by 90 · see citing works

Tearing down the walls: FDA approves next generation sequencing (NGS) assays for actionable cancer genomic aberrations

Allegretti, M., Fabi, A., Buglioni, S., Martayan, A., Conti, L., Pescarmona, E. O., Ciliberto, G., & Giacomini, P. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0702-x · Cited by 71 · see citing works

Real-world deployment of a fine-tuned pathology foundation model for lung cancer biomarker detection

Campanella, G., Kumar, N., Nanda, S., Singi, S., Fluder, E., Kwan, R., Muehlstedt, S., Pfarr, N., Schüffler, P. J., Häggström, I., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03780-x · Cited by 69 · see citing works

Pathogenic ATM Mutations in Cancer and a Genetic Basis for Radiotherapeutic Efficacy

Pitter, K. L., Casey, D. L., Lu, Y. C., Hannum, M., Zhang, Z., Song, X., Pecorari, I. L., McMillan, B., Ma, J., Samstein, R. M., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa095 · Cited by 69 · see citing works

Analysis of mutational signatures with yet another package for signature analysis

Hübschmann, D., Jopp‐Saile, L., Andresen, C., Krämer, S., Gu, Z., Heilig, C. E., Kreutzfeldt, S., Teleanu, V., Fröhling, S., Eils, R., et al. (2020) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22918 · Cited by 63 · see citing works

Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing

Thibodeau, M. L., O’Neill, K., Dixon, K., Reisle, C., Mungall, K., Krzywinski, M. I., Shen, Y., Lim, H. J., Cheng, D., Tse, K., et al. (2020) · Genetics in Medicine · doi:10.1038/s41436-020-0880-8 · Cited by 65 · see citing works

Integrated clinical and genomic analysis identifies driver events and molecular evolution of colitis-associated cancers

Chatila, W. K., Walch, H. S., Hechtman, J. F., Moyer, S. M., Sgambati, V., Faleck, D. M., Srivastava, A., Tang, L. H., Benhamida, J. K., Ismailgeci, D., et al. (2023) · Nature Communications · doi:10.1038/s41467-022-35592-9 · Cited by 58 · see citing works

Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing

Terraf, P., Pareja, F. G., Brown, D. N., Ceyhan‐Birsoy, O., Misyura, M., Rana, S., O'Reilly, E. M., Carlo, M. I., Aghajanian, C. A., Liu, Y. L., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.01.006 · Cited by 59 · see citing works

Early Detection of Pancreatic Cancer

Kenner, B. J., Abrams, N., Chari, S. T., Field, B. F., Goldberg, A. E., Hoos, W. A., Klimstra, D. S., Rothschild, L. J., Srivastava, S., Young, M. R., et al. (2021) · Pancreas · doi:10.1097/mpa.0000000000001882 · Cited by 63 · see citing works

Chromothripsis-Mediated Small Cell Lung Carcinoma

Rekhtman, N., Tischfield, S. E., Febres‐Aldana, C. A., Lee, J. J.-K., Chang, J. C., Herzberg, B. O., Selenica, P., Woo, H. J., Vanderbilt, C., Yang, S., et al. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0286 · Cited by 55 · see citing works

Molecular and phenotypic profiling of colorectal cancer patients in West Africa reveals biological insights

Alatise, O. I., Knapp, G., Sharma, A. S., Chatila, W. K., Arowolo, O. A., Olasehinde, O. O., Famurewa, O. C., Omisore, A. D., Komolafe, A. O., Olaofe, O. O., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-27106-w · Cited by 54 · see citing works

Expanded genetic testing of GIST patients identifies high proportion of non-syndromic patients with germline alterations

Mandelker, D. L., Marra, A., Mehta, N. N., Selenica, P., Yelskaya, Z., Yang, C., Somar, J., Mehine, M. M., Misyura, M., Baştürk, O., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-022-00342-z · Cited by 53 · see citing works

Variant Interpretation for Cancer (VIC): a computational tool for assessing clinical impacts of somatic variants

He, M. M., Li, Q., Yan, M., Cao, H., Hu, Y., He, K., Cao, K., Li, M. M., & Wang, K. (2019) · Genome Medicine · doi:10.1186/s13073-019-0664-4 · Cited by 56 · see citing works

Reversion mutations in germline BRCA1/2-mutant tumors reveal a BRCA-mediated phenotype in non-canonical histologies

Murciano‐Goroff, Y. R., Schram, A. M., Rosen, E. Y., Won, H. H., Gong, Y., Noronha, A. M., Janjigian, Y. Y., Stadler, Z. K., Chang, J. C., Yang, S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34109-8 · Cited by 52 · see citing works

Comparison of BRCA versus non-BRCA germline mutations and associated somatic mutation profiles in patients with unselected breast cancer

Chen, B., Zhang, G., Li, X., Ren, C., Wang, Y., Li, K., Mok, H., Cao, L., Wen, L., Jia, M., et al. (2020) · Aging · doi:10.18632/aging.102783 · Cited by 52 · see citing works

Genomic Determinants of Clinical Outcomes in Rhabdomyosarcoma

Casey, D. L., Wexler, L. H., Pitter, K. L., Samstein, R. M., Slotkin, E. K., & Wolden, S. L. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-2631 · Cited by 50 · see citing works

Characterization and Clinical Outcomes of DNA Mismatch Repair–deficient Small Bowel Adenocarcinoma

Latham, A. J., Shia, J., Patel, Z., Reidy‐Lagunes, D. L., Segal, N. H., Yaeger, R. D., Ganesh, K., Connell, L. C., Kemeny, N. E., Kelsen, D. P., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-2892 · Cited by 49 · see citing works

Toward automation of germline variant curation in clinical cancer genetics

Ravichandran, V., Shameer, Z., Kemel, Y. M., Walsh, M. F., Cadoo, K. A., Lipkin, S. M., Mandelker, D. L., Zhang, L., Stadler, Z. K., Robson, M. E., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0463-8 · Cited by 48 · see citing works

Germline alterations in patients with biliary tract cancers: A spectrum of significant and previously underappreciated findings

Maynard, H., Stadler, Z. K., Berger, M. F., Solit, D. B., Ly, M., Lowery, M. A., Mandelker, D. L., Zhang, L., Jordan, E., Dika, I. E., et al. (2020) · Cancer · doi:10.1002/cncr.32740 · Cited by 48 · see citing works

Assessing reproducibility of inherited variants detected with short-read whole genome sequencing

Pan, B., Ren, L., Onuchic, V., Guan, M., Kusko, R. L., Bruinsma, S., Trigg, L., Scherer, A., Ning, B., Zhang, C., et al. (2022) · Genome biology · doi:10.1186/s13059-021-02569-8 · Cited by 46 · see citing works

The role of genomics in global cancer prevention

Ginsburg, O., Ashton‐Prolla, P., Cantor, A., Mariosa, D., & Brennan, P. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0428-5 · Cited by 47 · see citing works

Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma

Mandelker, D. L., Marra, A., Zheng-Lin, B., Selenica, P., Blanco-Heredia, J., Zhu, Y., Gazzo, A. M., Wong, D., Yelskaya, Z., Rai, V., et al. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.00561 · Cited by 45 · see citing works

The pan-cancer landscape of prognostic germline variants in 10,582 patients

Chatrath, A., Przanowska, R. K., Kiran, S., Su, Z., Saha, S., Wilson, B., Tsunematsu, T., Ahn, J., Lee, K. Y., Paulsen, T., et al. (2020) · Genome Medicine · doi:10.1186/s13073-020-0718-7 · Cited by 43 · see citing works

Clinical and molecular characteristics of early-onset vs average-onset esophagogastric cancer

Lumish, M. A., Walch, H. S., Maron, S. B., Chatila, W. K., Kemel, Y. M., Maio, A., Ku, G. Y., Ilson, D. H., Won, E., Li, J., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad186 · Cited by 44 · see citing works

Diagnostic yield and clinical relevance of expanded genetic testing for cancer patients

Ceyhan‐Birsoy, O., Jayakumaran, G., Kemel, Y. M., Misyura, M., Aypar, U., Jairam, S., Yang, C., Li, Y., Mehta, N. N., Maio, A., et al. (2022) · Genome Medicine · doi:10.1186/s13073-022-01101-2 · Cited by 43 · see citing works

Disparities in cancer genetics care by race/ethnicity among pan‐cancer patients with pathogenic germline variants

Liu, Y. L., Maio, A., Kemel, Y. M., Salo‐Mullen, E. E., Sheehan, M. R., Tejada, P. R., Trottier, M., Arnold, A. G., Fleischut, M. H., Latham, A. J., et al. (2022) · Cancer · doi:10.1002/cncr.34434 · Cited by 42 · see citing works

Rb and p53-Deficient Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma Require Skp2 for Survival

Li, G. Z., Okada, T., Kim, Y.-M., Agaram, N. P., Sanchez-Vega, F., Shen, Y., Tsubokawa, N., Rios, J., Martin, A. S., Dickson, M. A., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1269 · Cited by 42 · see citing works

Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

Slotkin, E. K., Bowman, A. S., Levine, M. F., Cruz, F. S. D., Coutinho, D. F., Sanchez, G. D. I., Rosales, N., Modak, S. I., Tap, W. D., Gounder, M. M., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0722 · Cited by 42 · see citing works

Tumor-Based Genetic Testing and Familial Cancer RiskPreprint

Forman, A. D., & Sotelo, J. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036590 · Cited by 42 · see citing works

Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants

Rasnic, R., Brandes, N., Zuk, O., & Michal Linial, B. (2019) · BMC Cancer · doi:10.1186/s12885-019-5994-5 · Cited by 40 · see citing works

Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing

Truong, H., Sheikh, R., Kotecha, R. R., Kemel, Y. M., Reisz, P. A., Lenis, A. T., Mehta, N. N., Khurram, A., Vijai, J., Mandelker, D. L., et al. (2021) · European Urology Oncology · doi:10.1016/j.euo.2021.09.005 · Cited by 39 · see citing works

Microsatellite Instability and Mismatch Repair Deficiency Define a Distinct Subset of Lung Cancers Characterized by Smoking Exposure, High Tumor Mutational Burden, and Recurrent Somatic MLH1 Inactivation

Yang, S., Gedvilaite, E., Ptashkin, R. N., Chang, J. C., Ziegler, J., Mata, D. A., Villafania, L. B., Nafa, K., Hechtman, J. F., Benayed, R., et al. (2023) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2023.10.004 · Cited by 38 · see citing works

Neoplasia risk in patients with Lynch syndrome treated with immune checkpoint blockade

Harrold, E. C., Foote, M. B., Rousseau, B., Walch, H. S., Kemel, Y. M., Richards, A. L., Keane, F., Cercek, A., Yaeger, R. D., Rathkopf, D. E., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02544-9 · Cited by 36 · see citing works

Interim Analysis of a Prospective Validation of 2 Blood-Based Genomic Assessments (PPQ and NETest) to Determine the Clinical Efficacy of177Lu-DOTATATE in Neuroendocrine Tumors

Bodei, L., Raj, N. P., Do, R. K., Mauguen, A., Krebs, S. S., Reidy‐Lagunes, D. L., & Schöder, H. M. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.122.264363 · Cited by 35 · see citing works

Germline Sequencing Improves Tumor-Only Sequencing Interpretation in a Precision Genomic Study of Patients With Pediatric Solid Tumor

Schienda, J., Church, A. J., Corson, L. B., Decker, B. J., Clinton, C. M., Manning, D. K., Imamović, A., Reidy, D., Strand, G. R., Applebaum, M. A., et al. (2021) · JCO Precision Oncology · doi:10.1200/po.21.00281 · Cited by 34 · see citing works

Germline Pathogenic Variants Impact Clinicopathology of Advanced Lung Cancer

Mukherjee, S., Bandlamudi, C., Hellmann, M. D., Kemel, Y. M., Drill, E. N., Rizvi, H. A., Tkachuk, K. A., Khurram, A., Walsh, M. F., Zauderer, M. G., et al. (2022) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-1287 · Cited by 34 · see citing works

Novel Preclinical Patient-Derived Lung Cancer Models Reveal Inhibition of HER3 and MTOR Signaling as Therapeutic Strategies for NRG1 Fusion-Positive Cancers

Odintsov, I., Mattar, M. S., Lui, A. J. W., Offin, M. D., Kurzatkowski, C., Delasos, L., Khodos, I., Asher, M., Daly, R. M., Rekhtman, N., et al. (2021) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2021.03.013 · Cited by 32 · see citing works

Rare, Pathogenic Germline Variants in Fanconi Anemia Genes Increase Risk for Squamous Lung Cancer

Selvan, M. E., Klein, R. J., & Gumus, Z. H. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-2660 · Cited by 30 · see citing works

Next-generation sequencing for the general cancer patient.

Avila, M., & Meric‐Bernstam, F. (2019) · PubMed · Cited by 30 · see citing works

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applications

Parisi, C., Tagliamento, M., Belcaid, L., Aldea, M. D., Bayle, A., Remon-Masip, J., Italiano, A., Planchard, D., Besse, B., & Barlési, F. (2023) · The Journal of Liquid Biopsy · doi:10.1016/j.jlb.2023.100007 · Cited by 28 · see citing works

Deriving tumor purity from cancer next generation sequencing data: applications for quantitative ERBB2 (HER2) copy number analysis and germline inference of BRCA1 and BRCA2 mutations

Siegmund, S., Manning, D. K., Davineni, P. K., & Dong, F. (2022) · Modern Pathology · doi:10.1038/s41379-022-01083-x · Cited by 26 · see citing works

Germline genetic variation impacts clonal hematopoiesis landscape and progression to malignancy

Liu, J., Tran, D., Xue, L., Wiley, B. J., Vlasschaert, C., Watson, C. J., MacGregor, H. A. J., Zong, X., Chan, I. C. C., Das, I., et al. (2025) · Nature Genetics · doi:10.1038/s41588-025-02250-x · Cited by 25 · see citing works

Multiple Primary Cancers in Patients Undergoing Tumor-Normal Sequencing Define Novel Associations

Liu, Y. L., Cadoo, K. A., Mukherjee, S., Khurram, A., Tkachuk, K., Kemel, Y. M., Maio, A., Belhadj, S., Carlo, M. I., Latham, A. J., et al. (2021) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-21-0820 · Cited by 23 · see citing works

Mainstreaming of genomics in oncology: a nationwide survey of the genomics training needs of UK oncologists

Tutika, R. K., Bennett, J. A., Abraham, J., Snape, K. M. G., Tatton‐Brown, K., Kemp, Z., Copson, E., & Openshaw, M. R. (2023) · Clinical Medicine · doi:10.7861/clinmed.2022-0372 · Cited by 23 · see citing works

Comprehensive analysis of germline drivers in endometrial cancer

Gordhandas, S., Rios‐Doria, E., Cadoo, K. A., Catchings, A., Maio, A., Kemel, Y. M., Sheehan, M. R., Ranganathan, M., Green, D., Aryamvally, A., et al. (2023) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djad016 · Cited by 23 · see citing works

Next-Generation Sequencing of Advanced GI Tumors Reveals Individual Treatment Options

Bitzer, M., Ostermann, L., Horger, M., Biskup, S., Schulze, M., Ruhm, K., Hilke, F. J., Öner, Ö., Nikolaou, K., Schroeder, C., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00359 · Cited by 22 · see citing works

A tale of two pathways: Review of immune checkpoint inhibitors in DNA mismatch repair‐deficient and microsatellite instability‐high endometrial cancers

Liu, Y. L., & Weigelt, B. (2024) · Cancer · doi:10.1002/cncr.35267 · Cited by 22 · see citing works

Early age of onset and broad cancer spectrum persist in MSH6- and PMS2-associated Lynch syndrome

Liu, Y. L., Cadoo, K. A., Maio, A., Patel, Z., Kemel, Y. M., Salo‐Mullen, E. E., Catchings, A., Ranganathan, M., Kane, S. R., Soslow, R. A., et al. (2022) · Genetics in Medicine · doi:10.1016/j.gim.2022.02.016 · Cited by 22 · see citing works

Studies on the Safety and Efficacy of Pyrotinib in the Treatment of HER2- Positive Advanced Solid Tumors Excluding Breast Cancer

Yin, Y., Yang, H., Liu, Z., Tan, J., Zhu, C., Chen, M., Zhou, R., Wang, L., & Qian, J. (2020) · Cancer Management and Research · doi:10.2147/cmar.s281765 · Cited by 20 · see citing works

Opportunities and Challenges with Artificial Intelligence in Genomics

Kurant, D. E. (2022) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2022.09.007 · Cited by 20 · see citing works

Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome

Ranganathan, M., Sacca, R. E., Trottier, M., Maio, A., Kemel, Y. M., Salo‐Mullen, E. E., Catchings, A., Kane, S. R., Wang, C., Ravichandran, V., et al. (2023) · JCO Precision Oncology · doi:10.1200/po.22.00675 · Cited by 19 · see citing works

Comprehensive Genomic Analysis of Metastatic Non–Clear-Cell Renal Cell Carcinoma to Identify Therapeutic Targets

Carlo, M. I., Khan, N. A., Zehir, A., Patil, S., Ged, Y. M. A., Redzematovic, A., Coskey, D. T., Hyman, D. M., Ladanyi, M., Chen, Y., et al. (2019) · JCO Precision Oncology · doi:10.1200/po.18.00372 · Cited by 18 · see citing works

Immune checkpoint blockade in renal cell carcinoma

Rappold, P. M., Silagy, A. W., Kotecha, R. R., & Hakimi, A. A. (2021) · Journal of Surgical Oncology · doi:10.1002/jso.26339 · Cited by 18 · see citing works

The distinct clinical trajectory, metastatic sites, and immunobiology of microsatellite-instability-high cancers

Han, S., Chok, A. Y., Peh, D. Y. Y., Ho, J. Z.-M., Tan, E., Koo, S., Tan, I. B., & Ong, J. C.-A. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.933475 · Cited by 16 · see citing works

Detecting microsatellite instability in colorectal cancer using Transformer-based colonoscopy image classification and retrieval

Lo, C., Jiang, J., & Lin, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0292277 · Cited by 17 · see citing works

Prevalence and Preliminary Validation of Screening Criteria to Identify Carriers of Germline BAP1 Mutations

Zauderer, M. G., Jayakumaran, G., DuBoff, M. A., Zhang, L., Francis, J. H., Abramson, D. H., Cercek, A., Nash, G. M., Shoushtari, A. N., Chapman, P. B., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.07.002 · Cited by 16 · see citing works

Targeted next-generation sequencing for locally advanced prostate cancer in the Korean population

Suh, J., Jeong, C. W., Choi, S., Ku, J. H., Kim, H. H., Kim, K., & Kwak, C. H. (2020) · Korean journal of urology · doi:10.4111/icu.2020.61.2.127 · Cited by 16 · see citing works

Outcomes of Combination Platinum-Doublet Chemotherapy and Anti-PD(L)-1 Blockade in KRASG12C-Mutant Non-Small Cell Lung Cancer

Elkrief, A., Ricciuti, B., Alessi, J. V., Fei, T., Kalvin, H. L., Egger, J. V., Rizvi, H. A., Thummalapalli, R., Lamberti, G., Plodkowski, A. J., et al. (2023) · The Oncologist · doi:10.1093/oncolo/oyad197 · Cited by 15 · see citing works

Computational Analysis of Pathological Image Enables Interpretable Prediction for Microsatellite Instability

Zhu, J. S., Wu, W., Zhang, Y., Lin, S., Jiang, Y., Liu, R., Wang, X., & Zhang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.825353 · Cited by 15 · see citing works

Insertion of an Alu‐like element in MLH1 intron 7 as a novel cause of Lynch syndrome

Li, Y., Salo‐Mullen, E. E., Varghese, A. M., Trottier, M., Stadler, Z. K., & Zhang, L. (2020) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.1523 · Cited by 14 · see citing works

Fifty years of bone tumors

Bartelstein, M. K., & Boland, P. J. (2022) · Journal of Surgical Oncology · doi:10.1002/jso.27027 · Cited by 14 · see citing works

Pathogenic germline variants in patients with endometrial cancer of diverse ancestry

Liu, Y. L., Gordhandas, S., Arora, K. S., Rios‐Doria, E., Cadoo, K. A., Catchings, A., Maio, A., Kemel, Y. M., Sheehan, M. R., Salo‐Mullen, E. E., et al. (2023) · Cancer · doi:10.1002/cncr.35071 · Cited by 14 · see citing works

Present status of germline findings in precision medicine for Japanese cancer patients: issues in the current system

Higashigawa, S., Matsubayashi, H., Kiyozumi, Y., Kado, N., Nishimura, S., Oishi, T., Sugino, T., Fushiki, K., Shirasu, H., Yasui, H., et al. (2022) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyac046 · Cited by 14 · see citing works

Precision medicine for pancreatic cancer: characterizing the clinicogenomic landscape and outcomes of KRAS G12C-mutated disease

Keane, F., Chou, J. F., Walch, H. S., Schoenfeld, J. D., Singhal, A., Cowzer, D., Harrold, E. C., O'Connor, C. A., Park, W., Varghese, A. M., et al. (2024) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djae095 · Cited by 12 · see citing works

The Impact of Li-Fraumeni and Germline Retinoblastoma Mutations on Leiomyosarcoma Initiation, Outcomes, and Genetic Testing Recommendations

Dermawan, J. K. T. K., Abramson, D. H., Chiang, S., Hensley, M. L., Tap, W. D., Movva, S., Maki, R. G., Mandelker, D. L., & Antonescu, C. R. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1160 · Cited by 12 · see citing works

ATM Germline-Mutated Gastroesophageal Junction Adenocarcinomas: Clinical Descriptors, Molecular Characteristics, and Potential Therapeutic Implications

Jabbour, T. E., Misyura, M., Cowzer, D., Zimmermann, M., Rimkunas, V. M., Marra, A., Derakhshan, F. N., Selenica, P., Parilla, M., Setton, J. S., et al. (2022) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djac024 · Cited by 12 · see citing works

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

Safonov, A. M., Lee, M. K., Brown, D. N., Bielo, L. B., Mehine, M. M., Bandlamudi, C., O’Leary, B., Shao, H., Vicente, L., Muldoon, D. M., et al. (2026) · Nature · doi:10.1038/s41586-026-10197-0 · Cited by 13 · see citing works

The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer

Nguyen, V. T., Tessema, M., & Weissman, B. E. (2023) · Cancer treatment and research · doi:10.1007/978-3-031-45654-1_7 · Cited by 11 · see citing works

Universal germline genetic testing in patients with hematologic malignancies using DNA isolated from nail clippings

Ceyhan‐Birsoy, O., Fiala, E. M., Rana, S., Sheehan, M. R., Kennedy, J. A., Yelskaya, Z., Rai, V., Li, Y., Yang, C., Wong, D., et al. (2024) · Haematologica · doi:10.3324/haematol.2024.285055 · Cited by 11 · see citing works

Insertion of an SVA element in MSH2 as a novel cause of Lynch syndrome

Yang, C., Li, Y., Trottier, M., Farrell, M. P., Rai, V., Salo‐Mullen, E. E., Gallagher, D. J., Stadler, Z. K., van der Klift, H. M., & Zhang, L. (2021) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22950 · Cited by 11 · see citing works

A Simple, Accurate and Cost-Effective Capillary Electrophoresis Test with Computational Methods to Aid in Universal Microsatellite Instability Testing

Toh, J. W. T., Singh, P., Tangirala, V. A. A. S. K., Limmer, A., & Spring, K. J. (2021) · Cells · doi:10.3390/cells10061401 · Cited by 11 · see citing works

Next-Generation Sequencing in Oncology—A Guiding Compass for Targeted Therapy and Emerging Applications

Gales, L. N., Păun, M.-A., Butnariu, I., Simion, L., Manolescu, L. S. C., Trifanescu, O. G., & Anghel, R. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073123 · Cited by 10 · see citing works

Unique Genomic Alterations and Microbial Profiles Identified in Patients With Gastric Cancer of African, European, and Asian Ancestry

Abate, M., Walch, H. S., Arora, K. S., Vanderbilt, C., Fei, T., Drebin, H. M., Shimada, S., Maio, A., Kemel, Y. M., Stadler, Z. K., et al. (2023) · Annals of Surgery · doi:10.1097/sla.0000000000005970 · Cited by 10 · see citing works

Multicenter experience with large panel next-generation sequencing in patients with advanced solid cancers in Japan

Kato, S., Hayashi, T., Suehara, Y., Hamanoue, H., Yamanaka, S., Ichikawa, Y., Higurashi, T., Ohashi, K., Yamaguchi, S., Nozaki, Y., et al. (2018) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyy173 · Cited by 10 · see citing works

Methylation Analyses Reveal Promoter Hypermethylation as a Rare Cause of “Second Hit” in Germline BRCA1-Associated Pancreatic Ductal Adenocarcinoma

Zheng-Lin, B., Rainone, M., Varghese, A. M., Yu, K. H., Park, W., Berger, M. F., Mehine, M. M., Chou, J. F., Capanu, M., Mandelker, D. L., et al. (2022) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-022-00614-1 · Cited by 9 · see citing works

HEREDITARY ENDOCRINE TUMOURS: CURRENT STATE-OF-THE-ART AND RESEARCH OPPORTUNITIES: Challenges and opportunities in genetic counseling for hereditary endocrine neoplasia syndromes

Brock, P. L., Geurts, J. L., van Galen, P., Blouch, E. L., Welch, J. M., Kunz, A., Desrosiers, L., Gauerke, J. L., & Hyde, S. M. (2020) · Endocrine Related Cancer · doi:10.1530/erc-19-0454 · Cited by 9 · see citing works

Diffuse Pleural Mesotheliomas with Genomic Near-Haploidization: A Newly Recognized Subset with Distinct Clinical, Histologic, and Molecular Features

Yang, S., Jayakumaran, G., Benhamida, J. K., Febres‐Aldana, C. A., Fanaroff, R. E., Chang, J. C., Gedvilaite, E., Villafania, L. B., Sauter, J. L., Offin, M. D., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-0085 · Cited by 7 · see citing works

Therapeutic applications of germline testing for cancer predisposition genes in Asia in the real world

Cheo, S. W., Ong, P. Y., Ow, S. G. W., Chan, G. H. J., Tan, D. S. P., Lim, Y. W., Kong, H. L., Wong, A. L. A., Lim, S. E., Walsh, R. J., et al. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.103482 · Cited by 7 · see citing works

Additional file 1: of Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing

Cheng, D., Prasad, M., Chekaluk, Y. I., Benayed, R., Sadowska, J., Zehir, A., Syed, A., Wang, Y., Somar, J., Li, Y., et al. (2017) · Figshare · doi:10.6084/m9.figshare.5027072

MG-131 Incidental germline findings in tumour molecular profiling by next generation sequencing

Stockley, T. L., Thomasa, M., Harbia, D., Sukhai, M. A., Zhang, T., Pugha, T., Siu, L. L., Bedard, P. L., & Reid, S. K. (2015) · doi:10.1136/jmedgenet-2015-103577.22

Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach

Bhai, P. S., Levy, M. A., Rooney, K., Carere, D. A., Reilly, J., Kerkhof, J., Volodarsky, M., Stuart, A., Kadour, M., Panabaker, K., et al. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.698595 · Cited by 7 · see citing works

Use of Treatment-Focused Tumor Sequencing to Screen for Germline Cancer Predisposition

Lau, T., May, C. M., Dashti, Z. J. S., Swanson, L., Starks, E. R., Parker, J., Moore, R. A., Tucker, T., Bosdet, I., Young, S. S., et al. (2021) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2021.06.006 · Cited by 4 · see citing works

P535: Validation and real-life experience of a comprehensive, targeted next-generation sequencing panel for hereditary cancer predisposition

Pinard, A., Chua, A., Hodoğlugil, U., Martin, P.-M., Mak, J. S., Blanco, A. M., Sabbadini, M., Rajkovic, A., Devine, W. P., & Ziffle, J. V. (2023) · Genetics in Medicine Open · doi:10.1016/j.gimo.2023.100582